SCHEMBL4015367

SCHEMBL4015367

CCc1cc(CNC(=O)OC(C)(C)C)on1

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
EPHX2 P34913 1/20 0.52
NPC1 O15118 2/20 0.49
RAB9A P51151 2/20 0.49
KMT2A Q03164 2/20 0.44
SMN1; SMN2 Q16637 1/20 0.44
KDM4A O75164 1/20 0.40
SLC5A7 Q9GZV3 1/20 0.40
NR1H4 Q96RI1 1/20 0.40
MEN1 O00255 1/20 0.40
TDP1 Q9NUW8 1/20 0.40
L3MBTL1 Q9Y468 2/20 0.39
CYP1A2 P05177 1/20 0.39
CA1 P00915 2/20 0.39
CA2 P00918 2/20 0.39
CA9 Q16790 2/20 0.39
HDAC1 Q13547 1/20 0.39
HDAC6 Q9UBN7 1/20 0.39
CA4 P22748 1/20 0.39
CA7 P43166 1/20 0.39
CA12 O43570 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2123367 0.89 EPHX2 (0.41) EPHX2NPC1RAB9ASMN1; SMN2KDM4A
SCHEMBL9849328 0.86 NR1H4 (0.43) EPHX2NPC1RAB9AKDM4ANR1H4
SCHEMBL8235172 0.83 EPHX2 (0.49) EPHX2NPC1RAB9AKMT2ASMN1; SMN2
SCHEMBL30914650 0.83 KDM4A (0.42) SMN1; SMN2KDM4ANR1H4L3MBTL1CYP1A2
SCHEMBL1810190 0.82 NR1H4 (0.45) NPC1RAB9ASMN1; SMN2KDM4ANR1H4
SCHEMBL3884335 0.81 HTT (0.44) KMT2ASMN1; SMN2MEN1TDP1HDAC1
SCHEMBL4010124 0.81 NR1H4 (0.44) NPC1RAB9ASMN1; SMN2KDM4ANR1H4
SCHEMBL27773505 0.81 NR1H4 (0.47) NPC1RAB9ASMN1; SMN2KDM4ANR1H4
SCHEMBL3856479 0.80 GFER (0.40) EPHX2RAB9ASMN1; SMN2KDM4ANR1H4
SCHEMBL1178054 0.80 MAPT (0.43) NPC1RAB9AKMT2ASMN1; SMN2KDM4A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2044063-A1 PYRIMIDINE DERIVATIVES USEFUL IN THE TREATMENT OF CANCER Astra Zeneca AB (SE) 2009-04-08 EP disclosed
WO-2008001070-A1 PYRIMIDINE DERIVATIVES USEFUL IN THE TREATMENT OF CANCER ASTRAZENECA AB (SE) 2008-01-03 WO disclosed